Hepatic Impairment Completed Phase 1 Trials for Lemborexant (DB11951)

Also known as: Liver impairment / Diseases of liver (K70-K77) / Hepatic pathology / Fector hepaticus / [X]Diseases of the liver / Hepatopathy / Hepatic disease NOS / Hepatic disorder (NOS) / Disorder hepatic / Hepatic disorder NOS / Disease hepatocellular / Disorder liver / Hepatic disease / Hepatic disease (NOS) / Liver disorder / Liver Diseases / Unspecified disorder of liver

IndicationStatusPhase
DBCOND0031585 (Hepatic Impairment)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03440424Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared to Healthy SubjectsTreatment